N-(4-(4-((3-(4-(3-(4-methylpiperazin-1-yl)propoxy)phenyl)-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)phenoxy)phenyl)methanesulfonamide

ID: ALA3765759

Chembl Id: CHEMBL3765759

PubChem CID: 127040248

Max Phase: Preclinical

Molecular Formula: C31H34N4O5S3

Molecular Weight: 638.84

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CN1CCN(CCCOc2ccc(N3C(=O)/C(=C/c4ccc(Oc5ccc(NS(C)(=O)=O)cc5)cc4)SC3=S)cc2)CC1

Standard InChI:  InChI=1S/C31H34N4O5S3/c1-33-17-19-34(20-18-33)16-3-21-39-26-14-8-25(9-15-26)35-30(36)29(42-31(35)41)22-23-4-10-27(11-5-23)40-28-12-6-24(7-13-28)32-43(2,37)38/h4-15,22,32H,3,16-21H2,1-2H3/b29-22-

Standard InChI Key:  PKBQASYHKROUFI-IADYIPOJSA-N

Alternative Forms

  1. Parent:

    ALA3765759

    ---

Associated Targets(Human)

IKBKB Tchem Inhibitor of nuclear factor kappa B kinase beta subunit (5554 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Ikbkb Inhibitor of nuclear factor kappa-B kinase subunit beta (81 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 638.84Molecular Weight (Monoisotopic): 638.1691AlogP: 5.27#Rotatable Bonds: 11
Polar Surface Area: 91.42Molecular Species: NEUTRALHBA: 9HBD: 1
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 10.32CX Basic pKa: 8.11CX LogP: 4.26CX LogD: 3.48
Aromatic Rings: 3Heavy Atoms: 43QED Weighted: 0.17Np Likeness Score: -1.64

References

1. Kim D, Kim YG, Seo JH, Shin KJ..  (2016)  Identification and characterization of potent, selective and metabolically stable IKKβ inhibitor.,  26  (4): [PMID:26826731] [10.1016/j.bmcl.2016.01.065]

Source